Skip to main content
Figure 6 | BMC Biotechnology

Figure 6

From: High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells

Figure 6

Fed-batch optimization of transient scFv-Fc-RNase protein production in HEK293-6E cells. The vector pCMV-oriP1-scFv-Fc-RNase-4E3 was transiently transfected into HEK293-6E cells in 25 mL scale in shake flasks. One volume of fresh medium and 0.5% (w/v) tryptone TN1 was fed 48 h after transfection to all groups (group A, B, C). After 3 days two groups (group B, C) were fed with glucose and one group with additional 3.75 mM valproic acid (VPA, only group C). A) Volumetric yields of scFv-Fc-RNase protein were measured from supernatant samples taken from day 2 to 8 after transfection. B) ScFv-Fc-RNase was purified by protein A affinity chromatography from production supernatants harvested 8 days after transfection. The yield was calculated from total amount of purified protein and the final production volume. Protein recovery was determined as ratio of scFv-Fc-RNase after and before purification. C) Cell number, D) viability and and transfection efficiency (GFP co-transfection), E) Glucose and lactate as well as F) L-glutamine and glutamate were measured during the production until day 7. All groups were performed in independent triplicate samples. Mean values as well as standard deviations are given.

Back to article page